Breath Biopsy Testing: A Leading Driver Behind Impact Of Increased Respiratory Conditions On Breath Biopsy Testing Market Growth Market Expansion in 2025

Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.

What Will the Breath Biopsy Testing Industry Market Size Be by 2025?
The market size for breath biopsy tests has seen robust growth in the past years. Its expansion is projected to increase from $3.18 billion in 2024 to $3.43 billion in 2025, registering a compound annual growth rate (CAGR) of 7.8%. The growth witnessed during the historic period is due to factors such as government support initiatives, the transition towards non-invasive diagnostic methods, a rise in consumer awareness towards preventive healthcare, an increase in its use in cancer research, and its growing application in addressing metabolic disorders.

What's the Long-Term Growth Forecast for the Breath Biopsy Testing Market Size Through 2029?
In the coming years, the breath biopsy testing market is predicted to notably expand. By 2029, it is projected to reach a worth of $4.57 billion with a compound annual growth rate (CAGR) of 7.5%. This growth over the forecast period can be credited to an upsurge in respiratory illnesses, heightened awareness for early disease diagnosis, broadening of clinical research and trials, an increasing elderly population, and a rising prevalence of infectious diseases. Major trends within the forecast period consist of state-of-the-art advancements in breath analysis, a growing demand for personalized medicine, investments funnelled into healthcare infrastructure, cooperative endeavors between diagnostic companies and hospitals, and the integration of artificial intelligence and data analytics.

View the full report here:
https://www.thebusinessresearchcompany.com/report/breath-biopsy-testing-global-market-report

What Are the Key Growth Drivers Fueling the Breath Biopsy Testing Market Expansion?
The escalation of respiratory diseases is anticipated to boost the expansion of the breath biopsy testing market in the future. Conditions affecting lungs and airways, which limit an individual's ability to breath effectively, constitute respiratory diseases. The growth in such diseases can be linked to amplified environmental pollution, increased smoking habits, and the surge in chronic ailments like asthma and chronic obstructive pulmonary disease (COPD). Breath biopsy testing becomes necessary for these respiratory diseases as it provides a non-invasive, quick, and potentially more precise mode of identifying biomarkers connected to these disorders, thus enhancing early detection and treatment. For instance, a report by the Centers for Disease Control and Prevention, a US government agency, confirmed approximately 8,331 tuberculosis cases in the United States in 2022, a 5.9% rise from 2021, this was disclosed in November 2023. The incidence rate escalated to 2.5 cases per 100,000 people, indicating a 5.5% surge compared to the preceding year. Consequently, the increasing occurrence of respiratory diseases is projected to fuel the expansion of the breath biopsy testing market.

Get your free sample here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=19351&type=smp

What Are the Key Trends Driving Breath Biopsy Testing Market Growth?
Leading businesses within the breath biopsy testing sector are concentrating on the creation of innovative items such as breath analyzers, designed to detect asthma. Breath analyzers are tools used to identify and quantify certain compounds in a person's breath, providing insight into potential medical conditions and overall health. For example, GenWorks, a health solutions firm based in India, introduced the FenomPro breath analyzer in May 2023. This device uniquely offers speedy FeNO testing abilities, able to deliver results in a mere 28 seconds. Suited for use within clinical environments, it reliably aids in the diagnosis, screening, and tracking of asthma. The FenomPro is furnished with a rechargeable battery for easy transport, boasts an intuitive user interface, and effectively helps in determining if a patient requires treatment or a prescription for an inhaler.

How Is the Breath Biopsy Testing Market Segmented?
The breath biopsy testingmarket covered in this report is segmented -

1) By Type: Volatile Organic Compound Analyzers, Breath Biopsy Kits, Breath Sampler, Other Types
2) By Technology: Fuel Cell Technology, Semiconductor Sensor, Infrared (IR) Spectroscopy, Other Technologies
3) By Application: Hospitals, Clinics, Diagnostics Laboratories, Other Applications

Subsegments:
1) By Volatile Organic Compound (VOC) Analyzers: Gas Chromatography-Mass Spectrometry (GC-MS) Analyzers, Photoionization Detectors (PID), Electronic Nose Devices
2) By Breath Biopsy Kits: Sample Collection Kits, Analysis Kits For Specific Biomarkers, Packaging And Transport Kits
3) By Breath Sampler: Breath Collection Bags, Breath Sampling Tubes, Portable Breath Sampling Devices
4) By Other Types: Breath Testing Devices For Specific Conditions, Software For Data Analysis, Calibration Devices For Breath Analyzers

Tailor your insights and customize the full report here:
https://www.thebusinessresearchcompany.com/customise?id=19351&type=smp

Which Companies Are Leading the Charge in Breath Biopsy Testing Market Innovation?
Major companies operating in the breath biopsy testing market are Drägerwerk AG & Co. KGaA, Intoximeters Inc., Owlstone Medical Ltd., SKC Inc., Lifeloc Technologies Inc., Alcolizer Pty Ltd., Breathomix, Aerocrine AB, Bedfont Scientific Ltd., AK GlobalTech Corp., Alveo Technologies Inc., Andatech Pty Ltd., BACtrack, Biosensia Ltd., Ionicon, ket*onix AB, Lion Laboratories Limited, Menssana Research Inc., Microplex Inc., Quest Products Inc., Rapid Biosensor Systems Ltd., RoboScientific Ltd., Spirosure

Which Regions Are Leading the Global Breath Biopsy Testing Market in Revenue?
North America was the largest region in the breath biopsy testing market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the breath biopsy testing market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Purchase the full report today:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=19351

"This Report Supports:
1.Business Leaders & Investors - To identify growth opportunities, assess risks, and guide strategic decisions.
2.Manufacturers & Suppliers - To understand market trends, customer demand, and competitive positioning.
3.Policy Makers & Regulators - To track industry developments and align regulatory frameworks.
4.Consultants & Analysts - To support market entry, expansion strategies, and client advisory work."

Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.

Contact Us
Europe: +44 7882 955267,
Asia: +91 88972 63534,
Americas: +1 310-496-7795 or
Email: mailto:info@tbrc.info

Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.